Frequency and Distribution of ABO and Rh(D) Blood Groups in Glucose – 6 – Phosphate Dehydrogenase (G6PD) Deficient Neonates: A Hospital-Based Study in Uyo, Nigeria
Asian Hematology Research Journal,
Background: Glucose-6-phosphate dehydrogenase deficiency, an X-linked recessive disorder, is the commonest inherited red cell enzymopathy affecting mankind. It is known to cause severe neonatal hyperbilirubinaemia that can result in permanent neurologic damage or death. Numerous associations have been reported between ABO and Rh blood groups and increased or decreased susceptibility to diseases, including G6PD deficiency. However, studies on the association between G6PD deficiency and ABO and Rh blood groups have been largely inconsistent and limited.
Aims and Objectives: To estimate the level of G6PD activity among icteric neonates delivered at University of Uyo Teaching Hospital with the view of determining the prevalence of G6PD deficiency as well as to examine the association, if any, between G6PD and ABO and Rh blood types.
Methods: One hundred and fifty neonates were recruited into the study over a period of two years. Screening for G6PD deficiency was carried out using a quantitative in vitro test (Assay Pro) while the ABO and Rh(D) blood group phenotypes were determined using the standard tube method. The data were analyzed with SPSS version 23.0. Chi-square was used for test of significance.
Results: The overall prevalence of G6PD deficiency in the icteric neonates was 26.0%. The prevalence in males was 27.0% and 23.1% in females. Majority of the patients were of the O and Rh (D) positive blood types, the frequency and distribution of these blood group phenotypes among the patients were not different from the pattern reported in the general population in our clime. There was no statistically significant association between GGPD deficiency and the ABO and Rh (D) blood types of the patients(p<0.05).
Conclusion: There is a high prevalence of G6PD deficiency in icteric babies delivered at University of Uyo Teaching Hospital, Uyo, Nigeria. This justifies the need for routine neonatal screening for G6PD deficiency in all healthcare institutions in our environment. The association between G6PD deficiency and ABO and Rh (D) blood types was not statistically significant. However, we recommend that a large multicentre study be conducted in Nigeria and other African countries for the purpose of validating our results.
- Glucose-6-phosphate dehydrogenase deficiency
- icteric neonates
- ABO blood group
- Rh(D) blood group
How to Cite
Pace EJ, Brown CM, De George KC. Neonatal hyperbilinubinemia: An evidence-based approach. J Fam Pract. 2019;68:4-11.
Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: A worldwide Potential cause of severe Neonatal Hyperbilirubinaemia. Neo Reviews. 2000;1:32-39.
Egesie OJ, Joseph DE, Isiguzoro I, Egesie UG. Glucose-6- Phosphate dehydrogenase (G6PD) activity and deficiency in a population of Nigeria males resident in Jos Niger J Physiol Sci 2008;23:9-11.
Luzzatto L, Gordon – Smith EC. Inherited haemolytic anaemias, In: Hoffbrand V, Mitchel SL, Tuddenham EGD, editors. Postgraduate haematology 4th ed. Oxford: Butterworth Heinermann. 1999;134-139.
Ogunfowora OB, Daniel OJ. Neonatal jaundice and its management: Knowledge, Attitude, and practice of community Health workers in Nigeria. BMC Public Health. 2006;6:19-25.
Liaqat A, Liaqat A. Glucose-6-Phsophate dehydragenase deficiency in Jaundiced Neonates. JPMI. 2010;24:122-126.
Dallol A, Banni H, Gari MA, Al-Qahtani MH, Abuzenadeh AM, Al-Sayes F, et al. Five novel Glucose-6-Phosphate Dehydrogenase Deficiency Haplotypes Correlating with Disease severity. Journal of Translational Medicine. 2012;10:199-207.
Story JR, Olsson ML. Immunohaematology. 2009;25(2):48-49.
Franchini M, Liumbruno GM. ABO blood group: Old dogma, new perspectives. Clin chem. Lab Med. 2013;51:1545-53.
Eastland T. The histo-blood group ABO and tissue transplantation. Transfusion. 1998;38(10):975-988.
Breimer ME, Molne J, Norden G, rhdberg L, Thiel G, Svalander CT. blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis and secretor status. Transplantation. 2006;82(4):479-485.
Mahapatra S, Mishra D, Sahoo D, Sahoo BB. Study of prevalence of A2, A2B along with majorABO blood groups to minimize the transfusion reactions. International Journal of scientific Research (IJSR). 2016;5(3):189-90.
Simse S, de Jong CAM, overbeeke MAM. Sequence analysis of CDNA derived from reticulocyte mRNAS coding for Rh polypeptides and demonstration of E/e and C/c polymorphisms. Vox. Sang. 1994;67:203-209.
Urbaniak SJ. Greiss MA. RhD haemolytic disease of the fetus and the newborn. Blood Rev 2000;14:44-61.
Stella TC, Tannoa J, Connie MW, David Ff. high prevalence of red blood cell alloimmunization in sickle cell disease despite transfustion from Rh-matched minority donors. Blood 2013;122:1062-1071.
Liumbruno GM, Franchini M. Hemostasis, cancer, and ABO Blood group: The most recent evidence of association. J thromb Thrombolysis. 2014;38:160-6.
Franchini M, Lippi G. The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer. BMC med. 2015;13:7.
Wolpin BM, Chan At, Hartge P, Chanock SJ, Kraft P, Hunter DJ, Giovannucci EL, Fuchs CS. ABO blood group and the risk of pancreatic cancer. JN+1 cancer Inst. 2009;101:424-31.
Edgren G, Jjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, et al. risk of gastric cancer and peptic ulcers in relation to ABO blood type: A cohort study. Am J Epidemiol. 2010;172:1280-5.
Aird, bentall HH, Roberts JF. Relationship between cancer of stomach and the ABO blood groups. British Medical Journal. 1953;1(4814):799.
Anderson De, Haas C. blood type A and familial breast cancer. Cancer. 1984;54: 1845-1849.
Dahlen T, Clements M, Zhao J, Olsson ML, Edgren G. an agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk. Elife. 2021;10:e65658.
Ronco AL, Stoll M, De Stefani E, Maisonneuve JE, Mendoza BA, Deneo-Pellegrini H. Rh factor, family history and risk of breast cancer: A case – control study in Uruguay. Cancer Detect Prev. 2009;32:277-285.
Stamatakos M, Kontzoglou K, Safioleas P, Safioleas C, Manti C, Safioleas M. Breast Cancer incidence in Greek women in relation to ABO blood groups and Rh factor. Int semin surg Oncol. 2009;6:14.
Borghese B, Chartier M, Souza C, Santulli P, Lafay – Pillet M. ABO and Rhesus Blood Groups and Risk of Endometriosis in a French Caucasian Population of 633 Patients living in the Same Geographic Area. BioMed Research Internationa; 2014.
DOI: 10. 1155/2014/618964
ReidME, Bird GW. Associations between human red cell blood group antigens and disease. Transfuse Med Rev. 1990;4:47-55.
Lee BK, Zhang Z, Wikman A, Lindqvist PG, Reilly M. ABO and RhB blood groups and gestational hypertensive disorders: A population-based cohort study. BJOG: An International Journal of Obstetrics & Gynaecology. 2012;119:1232-1237.
Eslami ST, Nasirian H, Bayesh S, Nuri MM, Habibian N. Distribution of ABO Blood Groups and Rhesus (Rh) system in Glucose -6 – phosphate Dehydrogenase (G6PD) Deficient New-borns: A Regional Study in Iran. An Med Health Sci Res. 2018;8:262-265.
Saha H, Hawkins BR, Wong HB. Distribution of ABO and Rhesus Blood Groups in G6PD Deficient Chinese and Malay Newborns. Acta Genet. Med. Gemellol. 1975;24:131-135.
Saha H, Wong HB. Distribution of ABO and Rh blood groups among G6PD deficient and normal Chinese newborns. Int. Congr. Of Human Genetics, Paris; 1971.
Tarlov Ar, Brewer GJ, Carson PR, Alving AS. Primaquine sensitivity. Arch. Intern. Med. 1962;109:209-235.
Obasa TO, Mokuolu OA, Ojuuawo A. Glucose 6 Phosphate dehydrogenase lvels in babies delivered at the University of Ilorin Teaching Hospital. Niger J Paediatr. 2011;38(4):165-169.
Bain BJ, Lewis SM, Bates I. Basic Haematological Techniques. In: SM Lewis, BJ Bain, I Bates (Eds). Dacie and Lewis practical haematology 11th Edition. Philadelphia Churchill livingstone. 2008;36-39.
Oduola T, Thomas KD, Falana CO. Prevalence and Pattern of glucose – 6 – phosphate dehydrogenase in Ile-Ife, Nigeria. Journal of Medical laboratory Science. 2004;13(2):67-71.
Ademowo OG, Falusi AG. Molecular epidemiology and activity of erythrocyte G6PD variants in a homogenous Nigerian population. East Afr. Med. J. 2002;79(1): 42-44.
Ali q, Aqeel M, Iqbal H. frequency of Glucose-6-Phosphate dehydrogenase deficiency in neonatal jaundice. J Med Sci. 2011;19:167-170.
Amal AE, Nawal MK, Seham AA, Manal AF, Azza KA. Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency in Jaundiced Neonates in Egypt. Aust J of Basic and Appl Sci 2009; 3:2016-2023.
Pao M, Kulkarn A, Gupta V. Neonatal Screening for G6PD Deficiency. Indian J Paediat 2005;72:835-837.
Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. the Global prevalence of glucose – 6 – phosphate dehydrogenase deficiency: A systematic review and meta-analysis. Blood cells Mol Dis. 2009;42(3):267-278.
Ahmed H, Yakubu AM, Hendriakse RG. Neonatal Jaundice in Zaria: A second prospective study. An Trop Paediatr 1995;1:15-23.
Amiwero CE, Olatunji PO. Prevalence of G6PD Deficiency in Children Presenting with Jaundice in Ilorin, Nigeria. Int. J. Biomed and Hlth Sci. 2012;8:21-26.
Akanni EO, Oseni BSA, Agbona VO, Tijani BA, Tosan E, Fakunle EE, et al. Glucose – 6 – Phosphate dehydrogenase deficiency in blood donors and jaundiced neonates in Oshogbo, Nigeria. JMed Lab Diagn 2010;1:1-4.
Dawodu AH, Owa JA, Familusi JB. A prospective study of the Role of Bacterial Infection and G6PD deficiency in severe Neonatal Jaundice in Nigeria. Trop Geogr Med. 1984;36:127-132.
Bisoi S, Chakraborty S, Chattopadhyay D, Biswas B, Ray S. Glucose – 6 – phosphate Dehydrogenase Screening of Babies Born in a Tertiary cure Hospital in West Bengal. Indian J Public Health. 2012;56:146-148.
Lewis RA, Kay RW, Hathorn M. Sickle Cell Disease and Glucose – 6 – Phosphate Dehydrogenase. Acta Haematological (Base 1). 1966;36:399-411.
Minucci A, giardina B, Zuppi C, Capoluongo E. Glucose – 6 – phosphate Dehydrogenase Laboratory Assay: How, when and why? IUBMB Life. 2009;61:27-34.
Allison AC, Charles LJ, McGregor IA. Erythrocyte glucose – 6 – phosphate dehydrogenase deficiency in West Africa. Nature. 1961:190:1198-9.
Effiong CE, Aimaku VE, Bienzle V, Oyedeji CA, Ikpe DE Neonatal jaundice in Ibadan: Incidence, aetiological factors in babies born in hospitals. J Nat I Med Assoc 1975; 67:208-13.
Segel GB. Enzyme Defects. In: Berhman RE, Kliegman R, Jenson HB editors. Nelsons Textbook of Pediatrics. 18th ed Philadelphia: WB Saunders. 2007;1635-38.
Azma RZ, Hidayata N, Farisah NR, Hanidah NH, Ainoon O. Glucose-6-Phosphate dehydrogenase enzyme activity in normal term neonates and adults using OSMMR 2000 – Dkit with Hb – Normalization. Southeast Asian J Trop Med Public Health. 2010;41:982-988.
Reclos GJ, Hatzidakis CJ, Schulpis KH. Glucose-6-phosphate dehydrogenase deficiency neonatal screening: Preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening. JMed Screen. 2000;7:46-53.
George 10, Akani NA. Evaluation of Glucose -6-phosphate dehydrogenase deficiency in icetric newborns in Nigeria. Am J Trop Med pub Health. 2011;1:73-78.
Uko Ek, Agqunobi SN, Udoh JJ. Glucose-6-phosphate dehydrogenase levels in jaundiced neonates in Calabar. Niger J Med. 2003;12:98-102.
Al-Hiali SJ. Glucose-6-phosphate Dehydrogenase Deficiency among Neonates with Hyperbicrubinaemia in Western Iraq. J. Fac Med Baghdad. 2008; 50:431-434.
Veni DVK. The Effect of Gender on Serum Bilirubin Concentration in infants with Neonatal hyperbilirubinaemia. Int J Pharm Bio Sci. 2013;4:603- 608.
Ainoon O, Alawiyah A, Yu YH, Cheong SK. Semi-Quantitatie Screening Test for G6PD Deficiency Detects Severe Deficiency but misses a substantial Proportion of Partially Deficient Females. Southeast Asian Journal of Tropical Medicine and Public Health. 2003;34:404-405.
Simpore J, Damintoti K, Sawadogo L, Binet S, Nitiema H, Ovedraugo P, et al., Glucose-6-phosphate Dehydrogenase Decifiency and Sickle Cell Disease in Burkina Faso. Pakistan Journal of Biological Science. 2007;10:409-414.
Bouanga JC, Movele R, Prehu C, Wajcman H, Feingold J, Galaateros F. Glucose – 6 – Phosphate Dehydrogenase Deficiency and Homozygous Sickle Cell Disease in Congo. Human heredity. 1998;48:192-197.
Kaplan M, Herschal M, Hammerman C, Hoger JD, Stevenson DK. Hyperbilirubinaemia among African – American Glucose – 6 – Phosphate Dehydrogenase Deficient Neonates. Journal of Pediatrics 2004;114: 213-219.
Beutler E. G6PD deficiency. Blood. 1994;84:361336.
Dean AG, Dean JA, Coulombier D. Epi info version 6.0 A word Processing database and statistics programme for public health on IBM compatible microcomputers. Atlanta Centre for Disease Control and Prevention; 1995.
Anifowoshe AT, Owolodun OA, Akinseye KM, Iyiola OA, Oyeyemi BF. Gene frequencies of ABO and Rh blood groups in Nigeria. Egyptian Journal of Human Genetics. 2016;8:205-210.
Ufelle S, Neboh E, Ocheni S, Ikekpeazu E. The activity of glucose – 6 – phosphate dehydrogenase (G6PD) in stored blood. Orient Journal of Medicine. 2014;26:94-98.
Adam A, Dressler L, Sheba C, Seinberg A. A comparative study of blood groups distribution among normal and G-6-PD deficient subjects in Israel. 11th Int. Congr. Of Genetics, The Hague; 1963.
Saha N, Banerjee B. Erythrocyte G-6-PD deficiency among Chinese and Malays of Singapore. Trop. Geogr. Med. 1971;23: 141-144.
Abstract View: 36 times
PDF Download: 15 times